KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Return on Assets (2016 - 2025)

Historic Return on Assets for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to 0.08%.

  • Bristol Myers Squibb's Return on Assets rose 1700.0% to 0.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.08%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.08% for FY2025, which is 1700.0% up from last year.
  • Bristol Myers Squibb's Return on Assets amounted to 0.08% in Q4 2025, which was up 1700.0% from 0.06% recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Return on Assets ranged from a high of 0.09% in Q3 2023 and a low of 0.1% during Q4 2024
  • Over the past 5 years, Bristol Myers Squibb's median Return on Assets value was 0.06% (recorded in 2025), while the average stood at 0.02%.
  • Per our database at Business Quant, Bristol Myers Squibb's Return on Assets plummeted by -1800bps in 2024 and then soared by 1700bps in 2025.
  • Bristol Myers Squibb's Return on Assets (Quarter) stood at 0.06% in 2021, then increased by 2bps to 0.07% in 2022, then surged by 33bps to 0.09% in 2023, then crashed by -211bps to 0.1% in 2024, then skyrocketed by 179bps to 0.08% in 2025.
  • Its Return on Assets stands at 0.08% for Q4 2025, versus 0.06% for Q3 2025 and 0.05% for Q2 2025.